Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and NIH Clinical Center status. Updated the revision tag from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:46:19.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The history page now includes a glossary display option and color-coded legends for additions and deletions, and revision notes have been updated from v3.3.4 to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T06:11:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry (v3.3.4) and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:01:42.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.3.3' was added to the Record History, and the 'HHS Vulnerability Disclosure' item and the older 'Revision: v3.3.2' entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:29:45.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 to the history and removed Revision: v3.2.0. This represents a minor UI/version update to the page.
    Difference
    0.1%
    Check dated 2025-11-24T21:18:52.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Removed the banner warning about government funding lapses and processing delays that previously appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:43:54.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.